Category: Baxano SurgicalSyndicate content

FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week of August 11, 2014

August 14, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Analyst report: Dems can't stop Medtronic-Covidien merger

Baxano: Strong Q2, new patents can't appease Wall Street

August 8, 2014 by Arezu Sarvestani

Baxano's stock drops 25% after the company reports a 20% increase in sales during its 2nd quarter and the issuance of 2 new patents covering its minimally invasive spinal devices.

Baxano: Strong Q2, $10M raise, new patents and clinical trial can't appease Wall Street

Baxano Surgical (NSDQ:BAXS) just can't seem to do right by Wall Street.

Spine: Baxano Surgical closes $10M private placement

April 24, 2014 by Arezu Sarvestani

Baxano Surgical puts a ribbon on a private placement funding round after raising $10 million from unnamed investors.

Spine: Baxano Surgical closes $10M private placement

SafeStitch lures Baxano CFO Slattery to be new finance chief

September 25, 2013 by Brad Perriello

SafeStitch Medical lures Joseph Slattery to be its new CFO from Baxano, who names former Talecris Biotherapeutics exec Timothy Shannon as interim replacement.

SafeStitch lures Baxano CFO Slattery to be new finance chief
SafeStitch lures Baxano CFO Slattery to be new finance chief

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxano lowers full-year guidance amid widening losses, growing sales

August 14, 2013 by Arezu Sarvestani

Baxano fails to meet Wall Streets expectations during its 2nd quarter of 2013, during which the company reinvented itself as Baxano Surgical.

Baxano reinvents itself amid widening losses, growing sales

Baxano Surgical pays $6M to settle federal healthcare fraud beef

July 8, 2013 by Arezu Sarvestani

Baxano Surgical closes the books, without admitting wrong-doing, on a Justice Dept. investigation over allegations of healthcare fraud.

Baxano logo
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp